Co-Carriage Rates of Vancomycin-ResistantEnterococcusand Extended-Spectrum Beta-Lactamase-Producing Bacteria Among a Cohort of Intensive Care Unit Patients: Implications for an Active Surveillance Program
- 1 February 2004
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 25 (2) , 105-108
- https://doi.org/10.1086/502358
Abstract
Objective: To assess the co-colonization rates of extended-spectrum beta-lactamase (ESBL)-producing bacteria and vancomycin-resistantEnterococcus(VRE) obtained on active surveillance cultures.Design: Prospective cohort study.Setting: Medical and surgical intensive care units (ICUs) of a tertiary-care hospital.Patients: Patients admitted between September 2001 and November 2002 to the medical and surgical ICUs at the University of Maryland Medical System had active surveillance perirectal cultures performed. Samples were concurrently processed for VRE and ESBL-producing bacteria.Results: Of 1,362 patients who had active surveillance cultures on admission, 136 (10%) were colonized with VRE. Among these, 15 (positive predictive value, 11%) were co-colonized with ESBL. Among the 1,226 who were VRE negative, 1,209 were also ESBL negative (negative predictive value, 99%). Among the 1,362 who had active surveillance cultures on admission, 32 (2%) were colonized with ESBL. Among these, 15 (47%) were co-colonized with VRE. Of the 32 patients colonized with ESBL, 10 (31%) had positive clinical cultures for ESBL on the same hospital admission. For these 10 patients, the surveillance cultures were positive an average of 2.7 days earlier than the clinical cultures.Conclusions: Patients who are colonized with VRE can also be co-colonized with other antibiotic-resistant bacteria such as ESBL-producing bacteria. Our study is the first to measure co-colonization rates of VRE and ESBL-producing bacteria. Isolating VRE-colonized patients would isolate 47% of the ESBL-colonized patients without the need for further testing. Hence, active surveillance for VRE should also theoretically diminish the amount of patient-to-patient transmission of ESBL-producing bacteria.Keywords
This publication has 21 references indexed in Scilit:
- Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-ResistantEnterococcusInfection Control & Hospital Epidemiology, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Vancomycin-Resistant Enterococci in Intensive Care UnitsArchives of internal medicine (1960), 1999
- Control of Vancomycin-Resistant Enterococci at a Community Hospital: Efficacy of Patient and Staff CohortingInfection Control & Hospital Epidemiology, 1999
- Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control ImplicationsInfection Control & Hospital Epidemiology, 1997
- Natural History of Colonization with Vancoimycin-Resistant Enterococcus faeciumInfection Control & Hospital Epidemiology, 1995
- The challenge of vancomycin-resistant enterococci: A clinical and epidemiologic studyAmerican Journal of Infection Control, 1995
- In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 1989
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescensInfection, 1983